Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about BLOOD-BRAIN BARRIER DYSFUNCTION: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
BLOOD-BRAIN BARRIER DYSFUNCTION is a concept in neurodegeneration research. Key relationships include: activates, contributes to, associated with. Associated with ALS, Aging, Als. Connected to 110 entities in the SciDEX knowledge graph.
| Name | BLOOD-BRAIN BARRIER DYSFUNCTION |
| Category | evidence:strong |
| Summary | Page for Blood-Brain Barrier Dysfunction in Neurodegeneration |
| Key Genes/Proteins | ALS, ALZHEIMER'S DISEASE, ALZHEIMER |
| Related Diseases | Diabetes, Alzheimer, Inflammation, Neuroinflammation, NEUROINFLAMMATION |
| Related Pathways | Blood-Brain Barrier |
Knowledge base pages for this entity
graph TD
BLOOD_BRAIN_BARRIER_DYSFUNCTIO["BLOOD-BRAIN BARRIER DYSFUNCTION"]
BLOOD_BRAIN_BARRIER_DYSFUNCTIO -->|"activates"| sepsis_associated_encephalopat["sepsis-associated encephalopathy"]
BLOOD_BRAIN_BARRIER_DYSFUNCTIO -->|"inhibits"| Diabetes["Diabetes"]
BLOOD_BRAIN_BARRIER_DYSFUNCTIO -->|"inhibits"| Aging["Aging"]
BLOOD_BRAIN_BARRIER_DYSFUNCTIO -->|"regulates"| Stroke["Stroke"]
BLOOD_BRAIN_BARRIER_DYSFUNCTIO -->|"inhibits"| Als["Als"]
BLOOD_BRAIN_BARRIER_DYSFUNCTIO -->|"inhibits"| Ischemia["Ischemia"]
BLOOD_BRAIN_BARRIER_DYSFUNCTIO -->|"inhibits"| Ms["Ms"]
BLOOD_BRAIN_BARRIER_DYSFUNCTIO -->|"contributes to"| Alzheimer["Alzheimer"]
BLOOD_BRAIN_BARRIER_DYSFUNCTIO -->|"contributes to"| ALS["ALS"]
pericyte_senescence["pericyte senescence"] -->|"causes"| BLOOD_BRAIN_BARRIER_DYSFUNCTIO
pro_inflammatory_cytokines["pro-inflammatory cytokines"] -->|"activates"| BLOOD_BRAIN_BARRIER_DYSFUNCTIO
Amyloid__["Amyloid beta"] -->|"causes"| BLOOD_BRAIN_BARRIER_DYSFUNCTIO
SMAD2["SMAD2"] -->|"inhibits"| BLOOD_BRAIN_BARRIER_DYSFUNCTIO
AMYLOID["AMYLOID"] -->|"contributes to"| BLOOD_BRAIN_BARRIER_DYSFUNCTIO
ALZHEIMER_S_DISEASE["ALZHEIMER'S DISEASE"] -->|"contributes to"| BLOOD_BRAIN_BARRIER_DYSFUNCTIO
NEURODEGENERATIVE_DISORDERS["NEURODEGENERATIVE DISORDERS"] -->|"contributes to"| BLOOD_BRAIN_BARRIER_DYSFUNCTIO
TAU_PATHOLOGY["TAU PATHOLOGY"] -->|"contributes to"| BLOOD_BRAIN_BARRIER_DYSFUNCTIO
ALZHEIMER["ALZHEIMER"] -->|"contributes to"| BLOOD_BRAIN_BARRIER_DYSFUNCTIO
AND["AND"] -->|"contributes to"| BLOOD_BRAIN_BARRIER_DYSFUNCTIO| Target | Relation | Type | Str |
|---|---|---|---|
| Blood-Brain Barrier | activates | pathway | 0.80 |
| Diabetes | inhibits | disease | 0.75 |
| Alzheimer | activates | disease | 0.75 |
| Inflammation | associated_with | disease | 0.75 |
| Neuroinflammation | associated_with | disease | 0.75 |
| ALS | associated_with | gene | 0.70 |
| Blood-Brain Barrier | associated_with | pathway | 0.70 |
| ALZHEIMER'S DISEASE | activates | gene | 0.70 |
| ALZHEIMER | activates | gene | 0.70 |
| NEUROINFLAMMATION | inhibits | phenotype | 0.70 |
| NEURODEGENERATION | treats | phenotype | 0.70 |
| Stroke | associated_with | disease | 0.65 |
| Ms | associated_with | disease | 0.65 |
| Aging | inhibits | disease | 0.65 |
| Stroke | regulates | disease | 0.65 |
| Als | inhibits | disease | 0.65 |
| Ischemia | inhibits | disease | 0.65 |
| Ms | inhibits | disease | 0.65 |
| Aging | contributes_to | disease | 0.65 |
| Alzheimer | contributes_to | disease | 0.65 |
| ALS | contributes_to | disease | 0.65 |
| Huntington | contributes_to | disease | 0.65 |
| Dementia | contributes_to | disease | 0.65 |
| ALS | activates | disease | 0.65 |
| Stroke | activates | disease | 0.65 |
| Ischemia | therapeutic_target | disease | 0.65 |
| Ms | therapeutic_target | disease | 0.65 |
| Aging | associated_with | disease | 0.65 |
| Hypertension | inhibits | disease | 0.65 |
| Alzheimer | inhibits | disease | 0.65 |
| Neurodegeneration | inhibits | disease | 0.65 |
| Dementia | inhibits | disease | 0.65 |
| Aging | biomarker_for | disease | 0.65 |
| Alzheimer | associated_with | disease | 0.65 |
| Dementia | biomarker_for | disease | 0.65 |
| Traumatic Brain Injury | associated_with | disease | 0.65 |
| Ms | biomarker_for | disease | 0.65 |
| Atherosclerosis | biomarker_for | disease | 0.65 |
| Aging | implicated_in | disease | 0.65 |
| Als | biomarker_for | disease | 0.65 |
| Stroke | biomarker_for | disease | 0.65 |
| Neuroinflammation | implicated_in | disease | 0.65 |
| Inflammation | implicated_in | disease | 0.65 |
| Senescence | associated_with | disease | 0.65 |
| Neurodegeneration | associated_with | disease | 0.65 |
| Dementia | activates | disease | 0.65 |
| Cerebral Amyloid Angiopathy | activates | disease | 0.65 |
| Vascular Dementia | activates | disease | 0.65 |
| ALS | biomarker_for | disease | 0.65 |
| Parkinson | activates | disease | 0.65 |
| Source | Relation | Type | Str |
|---|---|---|---|
| NEUROINFLAMMATION | exacerbates | phenotype | 0.70 |
| SMAD2 | inhibits | gene | 0.60 |
| AMYLOID | contributes_to | gene | 0.60 |
| ALZHEIMER'S DISEASE | contributes_to | gene | 0.60 |
| NEURODEGENERATIVE DISORDERS | contributes_to | gene | 0.60 |
| TAU PATHOLOGY | contributes_to | gene | 0.60 |
| ALZHEIMER | contributes_to | gene | 0.60 |
| APOE4 | causes | gene | 0.60 |
| PERICYTE | contributes_to | gene | 0.60 |
| DEMENTIA | contributes_to | gene | 0.60 |
| ASTROCYTES | therapeutic_target | gene | 0.60 |
| STROKE | associated_with | gene | 0.60 |
| OXIDATIVE STRESS | therapeutic_target | gene | 0.60 |
| MICROGLIA | therapeutic_target | gene | 0.60 |
| NEUROINFLAMMATION | associated_with | gene | 0.60 |
| BRAIN INJURY | therapeutic_target | gene | 0.60 |
| OVERVIEW | therapeutic_target | gene | 0.60 |
| ALZHEIMER'S DISEASE | activates | gene | 0.60 |
| ALZHEIMER | activates | gene | 0.60 |
| ICAM1 | activates | gene | 0.60 |
| ABCD2 | activates | gene | 0.60 |
| BRAIN INJURY | associated_with | gene | 0.60 |
| OVERVIEW | associated_with | gene | 0.60 |
| AND | associated_with | gene | 0.60 |
| STROKE | biomarker_for | gene | 0.60 |
| IL-6 | biomarker_for | gene | 0.60 |
| AND | biomarker_for | gene | 0.60 |
| EXERCISE | associated_with | gene | 0.60 |
| NRF2 | activates | gene | 0.60 |
| AGING | associated_with | gene | 0.60 |
| NEURODEGENERATION | associated_with | gene | 0.60 |
| DEMENTIA | activates | gene | 0.60 |
| ALZHEIMER DISEASE | activates | gene | 0.60 |
| INFLAMMATION | associated_with | gene | 0.60 |
| EPILEPSY | activates | gene | 0.60 |
| HUNTINGTON | contributes_to | gene | 0.60 |
| AND | activates | gene | 0.60 |
| STROKE | activates | gene | 0.60 |
| ALZHEIMER | associated_with | gene | 0.60 |
| ALZHEIMER'S DISEASE | associated_with | gene | 0.60 |
| OXIDATIVE STRESS | associated_with | gene | 0.60 |
| FERROPTOSIS | activates | gene | 0.60 |
| NEURODEGENERATIVE DISORDERS | activates | gene | 0.60 |
| APOE4 | associated_with | gene | 0.50 |
| Neuroinflammation | interacts_with | process | 0.50 |
| oxidative stress | interacts_with | phenotype | 0.50 |
| BRAIN INJURY | interacts_with | concept | 0.50 |
| HMGB1 | activates | gene | 0.50 |
| HO-1 | activates | protein | 0.50 |
| ferroptosis | activates | phenotype | 0.50 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| No targeting hypotheses | |||
Scientific analyses that reference this entity
No analyses mention this entity
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||